XML 86 R53.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Quarterly Data (Unaudited) (Tables)
12 Months Ended
Dec. 31, 2018
Quarterly Financial Data [Abstract]  
Schedule of Quarterly Data
A summary of quarterly data(1) follows (in thousands, except per share data):

 
For the Three Months Ended

 
March 31,
 
June 30,
 
September 30,
 
December 31,

 
 

 
 

 
 

 
 

2018
 
 

 
 

 
 

 
 

Revenue
 
$
537,656

 
$
580,752

 
$
545,448

 
$
549,386

Gross profit
 
303,099

 
332,439

 
305,643

 
300,361

Operating income
 
113,044

 
145,594

 
117,350

 
115,347

Net income attributable to IDEXX Laboratories, Inc. stockholders
 
89,451

 
108,691

 
93,251

 
85,638

Earnings per share:
 
 
 
 
 
 
 
 
Basic
 
$
1.02

 
$
1.25

 
$
1.07

 
$
0.99

Diluted
 
$
1.01

 
$
1.23

 
$
1.05

 
$
0.98


 
 
 
 
 
 
 
 
2017
 
 
 
 
 
 
 
 
Revenue
 
$
462,021

 
$
508,940

 
$
491,976

 
$
506,121

Gross profit
 
258,191

 
292,715

 
274,002

 
272,474

Operating income
 
92,243

 
122,564

 
100,413

 
97,808

Net income attributable to IDEXX Laboratories, Inc. stockholders
 
69,019

 
85,357

 
70,511

 
38,257

Earnings per share:
 
 
 
 
 
 
 
 
Basic
 
$
0.78

 
$
0.97

 
$
0.81

 
$
0.44

Diluted
 
$
0.77

 
$
0.95

 
$
0.79

 
$
0.43

(1)
Amounts presented may not recalculate to full-year totals due to rounding.